Lv61
1978 积分 2022-10-19 加入
Improved Quantitative Structure-Activity Relationship (QSAR) Models to Predict the Activity of Hydroxamic Acids as HDAC Inhibitors against Malaria Parasites
1个月前
已关闭
Sulfanylbenzamides with Unique Side Chains to Improve Metabolic Stability, Pharmacokinetics, and Anti-HIV Activity
1个月前
已完结
Microglial phagocytosis in Alzheimer disease
1个月前
已完结
Discovery of Novel Harmine Derivatives as Potent, Selective, and Brain Permeable GSK3β Inhibitors with Effective In Vivo anti-AD Activity
2个月前
已完结
Small Molecule-Drug Conjugates: An Emerging Drug Design Strategy for Targeted Therapeutics
2个月前
已完结
What Do Oral Drugs Really Look Like? Dose Regimen, Pharmacokinetics, and Safety of Recently Approved Small-Molecule Oral Drugs
2个月前
已完结
Zervimesine, a Small Sigma-2 Receptor Selective Modulator for Alzheimer’s Disease
2个月前
已完结
TREM2 activation by first-in-class direct small molecule agonists: DEL screening, optimization, biophysical validation, and functional characterization
2个月前
已完结
Recent development in PDE4D-targeted inhibitors for Alzheimer’s disease therapy
2个月前
已完结
Design and Synthesis of Novel N-(1H-pyrazol-3-yl)pyrimidin-4-amine Aurora/HDAC Dual Inhibitors for Colorectal Cancer Treatment
2个月前
已完结
皖公网安备34019202002308
